Telehealth didn’t just remove waiting rooms. It also removed many of the frictions that used to make fraud harder. When prescribing and follow‑up visits moved online at scale during COVID-19, telemedicine became a lifeline for patients who could not travel, did not have access to local specialists, or wanted mental health care without exposing a private struggle to everyone around them.
But the same shift also created new attack surfaces. During the COVID-19 era, federal policymakers expanded telemedicine flexibilities for prescribing controlled medications, and those flexibilities have remained in place through the end of 2026 while longer‑term rules are still being worked out. Regulators have continued to warn providers about telehealth fraud risks and have issued dedicated fraud alerts and oversight work focused on the category. In that environment, AI‑driven identity and risk systems are quickly becoming the trust layer that allows telehealth to keep growing without collapsing under fraud and abuse.
How Fraud has Adapted to Telehealth
In a physical clinic, there are small checkpoints everywhere. A person shows up in front of staff. An ID is handled in person. A provider can notice hesitation, inconsistency, or behaviour that does not fit the stated profile in the waiting room or exam room.
When care moves online, those informal defences weaken. Remote intake and prescribing workflows make it easier for bad actors to slip through unnoticed. Common patterns include:
- Stolen IDs used to get through remote registration.
- Synthetic identities assembled from real and fabricated data.
- Coordinated drug‑seeking behaviour that moves quickly across providers and state lines.
- “Doctor shopping” — visiting multiple prescribers to obtain overlapping prescriptions for controlled substances without fully disclosing prior prescriptions.
Doctor shopping is particularly hard to spot when records are fragmented and clinicians are already working under time pressure. This is where AI becomes useful. It can connect signals that are easy to miss in a manual workflow, flag unusual behaviour early, and help telehealth providers catch fraud before it turns into a clinical or operational problem.
ALSO READ: Why Behaviour Traceability and Clinician Oversight Matter
Why AI has to be in the Loop
It is tempting to assume that a larger support team or stricter manual review can close the gap. In practice, manual verification cannot handle the volume and speed of cases in a modern telehealth operation. Humans are slow at repetitive document review, inconsistent at spotting subtle anomalies, and poorly positioned to connect fragmented risk signals in real time.
Even something as basic as controlled‑substance monitoring becomes cumbersome when it depends on staff hopping between systems. Many providers now rely on Prescription Drug Monitoring Programs (PDMPs), which are state‑run electronic databases that track controlled‑substance prescriptions and help clinicians identify patients who may be at risk. The question is whether your systems can use that data quickly and consistently enough to be effective before a visit moves forward.
AI is not a silver bullet. But it is uniquely suited to scanning large volumes of structured and semi‑structured information, spotting irregularities across systems, and doing repetitive verification work with far more consistency than a human team can sustain all day. In other words, it provides the first‑line screening that manual processes alone cannot.
How AI Builds Trust in Telehealth
For telehealth providers, AI’s role in fraud prevention falls into three main jobs: identity proofing, pattern recognition and risk scoring, and securing the prescribing workflow.
1. Identity proofing at scale
Modern digital identity frameworks break remote identity proofing into three steps: validation, resolution, and verification. In a telehealth context, that usually means:
- Document authentication: Systems scan a government‑issued ID and look for expected security features, layout, and data consistency to identify probable forgeries.
- Liveness detection: Webcam‑based checks confirm that there is a real person on screen rather than a static image, replayed video, or deepfake.
- Face matching: Facial recognition compares the live image against the photo on the authenticated ID before the patient is cleared for consultation.
These checks run in the background and are designed to be fast enough that they do not add noticeable friction for genuine patients.
2. Pattern‑level risk detection
The second job is pattern recognition across visits, clinicians, and prescription histories.
- Automated integration into state PDMPs can flag possible doctor shopping across providers or state lines before a clinician writes another prescription.
- Smart intake and AI‑driven chart review can examine medical history, prescribing patterns, and inconsistencies in the record.
- Red flags show up as high‑complexity requests for Schedule II–V stimulants without supporting documentation, attempts to bypass evaluation steps, refusal to provide records from an existing primary clinician, or a history that does not line up with the diagnostic criteria a clinician would normally expect to see.
Behind the scenes, models can assign a risk score that reflects the overall pattern, not just one anomaly. Cases above a certain threshold can then be routed for additional verification or specialist review instead of proceeding as routine visits.
3. Securing electronic prescribing
Finally, the prescribing workflow itself needs to be hardened. Electronic prescribing (eRx) that links directly to pharmacies through secure, encrypted channels makes prescriptions much harder to forge or alter compared to paper‑based workflows or looser systems that can be manipulated.
When identity proofing, pattern detection, and secure prescribing are wired together, providers get a more reliable end‑to‑end picture: they know who they are treating, whether the request fits the patient’s history and risk profile, and that prescriptions are transmitted in a tamper‑resistant way.
ALSO READ: How Ahead Health is Turning Algorithms Into Preventive Care
Short‑term Volume vs Long‑term Care
There is a catch. For a growing company, tightening fraud detection can look like a trade‑off between profit and process in the short term.
At MEDvidi, when we strengthened identity checks and risk detection, patient volume did go down. A measurable portion of appointments turned out to represent fraud or drug‑seeking behaviour and disappeared from the pipeline. On a spreadsheet, that can look like a negative outcome.
In practice, it had the opposite effect on our care model. Our providers spent more time with patients who were genuinely seeking mental health care. Our outcomes data became more accurate and more useful because it reflected real treatment rather than noise from inappropriate cases. The environment became closer to what we wanted to build in the first place: a sustainable, evidence‑driven practice instead of a volume‑driven operation sitting on top of unchecked risk.
Don’t Bolt Compliance on Later
Many telehealth companies still treat this as a compliance project they can tackle “after we scale.” That approach often backfires.
When safety checks live outside the care model, support staff end up running ad‑hoc verifications, communicating partial information to clinicians, and relying on email or chat threads to explain what happened. The provider still does extra work to interpret those signals, and gaps remain.
A more effective approach is to place the AI‑driven trust layer inside the care model itself, so that verification and risk detection are part of the workflow from the beginning. That means:
- Identity checks and PDMP queries run automatically as part of intake.
- Risk scores and key flags are surfaced in the clinician’s view before or during the visit.
- Clear policies define what happens when a case crosses certain risk thresholds, including when a visit should be escalated, rescheduled, or declined.
When this is done well, the clinician’s experience becomes more focused. They do not need to sit through the mechanics of liveness detection or document forensics. Those high‑intensity administrative tasks run in the background. What reaches the clinician is a verified identity, relevant prescribing history, any flagged inconsistencies, and a clearer picture of whether the case needs closer attention. The doctor still makes the decision. AI simply moves non‑clinical burdens away from the caregiver so they can exercise their judgment to the best of their abilities.
ALSO READ: Claude Mythos Has Changed the Vulnerability Curve. Can Defenders Keep Up?
AI is Not Replacing Your Doctor
Healthcare has already seen what happens when business logic leans too heavily on medical decisions. The goal is not to hand prescribing or diagnosis over to software and hope for the best.
Instead, AI should be used for what it is genuinely good at: reviewing large volumes of data, spotting irregularities across systems, and handling repetitive verification work with consistent quality. Clinicians define the standards of care and make the final calls. AI systems give them better inputs, better signal‑to‑noise, and more time to practise medicine instead of chasing paperwork.
In a Nutshell
Telehealth is going to remain a major part of care delivery. The access problem is too large, and the convenience for patients is too crucial, for the industry to move backwards. But access without trust cannot be sustained.
If remote care is going to keep growing, the systems underneath it need to get better at distinguishing real patients from stolen identities, legitimate treatment from coordinated drug‑seeking, and responsible prescribing from volume‑driven shortcuts. AI‑driven identity, risk, and prescribing controls are not a replacement for clinicians — they are the infrastructure that keeps telehealth safe enough to last.
ALSO READ: Synthetic Data for Drug Discovery: How SandboxAQ’s SAIR Dataset Powers Scientific AI
Note: The description of Prescription Drug Monitoring Programs as state‑run electronic databases tracking controlled‑substance prescriptions aligns with CDC guidance on PDMPs. The use of “doctor shopping” here follows clinical and public‑health definitions describing patients who visit multiple providers to obtain overlapping prescriptions for controlled substances without full disclosure
